Background: Exposure to intrauterine growth retardation (IUGR) can have a negative impact on nephrogenesis resulting in limited fetal kidney development and supporting the hypothesis that IUGR represents a risk for renal function and long-term renal disease. Cystatin-C (Cys-C), a strong inhibitor of cysteine proteinases, is freely filtered by the kidney glomerulus and is reabsorbed by the tubules, where it is almost totally catabolized; what remains is subsequently eliminated in urine. In tubular diseases and in hyperfiltration conditions, it seems reasonable to postulate that Cys-C degradation would decrease, and consequently an increase in its urinary elimination would be observed. Objectives: The aim of this study was to investigate the urinary excretion of Cys-C simultaneously with the assessment of renal volumes in adequate for gestational age (AGA) and IUGR neonates in order to identify its clinical value in IUGR. Methods: Urinary Cys-C levels were measured using the enzyme immunoassay DetectX® Human Cystatin C kit in IUGR and AGA neonates. Whole renal and renal cortex volumes were assessed with ultrasounds (Vocal II; Software, GE). Results: Urinary Cys-C levels in IUGR were significantly higher than those found in AGA and were negatively correlated to reduced whole renal and renal cortex volumes. Conclusions: The increased levels of Cys-C in the urine of neonates with IUGR were significantly associated with reduced renal/renal cortex volumes, suggesting that Cys-C could be taken as a surrogate of nephron mass. It also could be used as an early biochemical marker to identify IUGR neonates at high risk of developing long-term renal disease and to select patients for monitoring during childhood.

1.
Zaffanello M, Brugnara M, Bruno C, Franchi B, Talamini G, Guidi G, Cataldi L, Biban P, Mella R, Fanos V: Renal function and volume of infants born with a very low birth-weight: a preliminary cross-sectional study. Acta Paediatr 2010;99:1192-1198.
2.
Manalich R, Reyes L, Herrera M, Melendi C, Fundora I: Relationship between weight at birth and the number and size of renal glomeruli in humans: a histomorphometric study. Kidney Int 2000;58:770-773.
3.
Hinchliffe SA, Lynch MR, Sargent PH, Howard CV, Van Velzen D: The effect of intrauterine growth retardation on the development of renal nephrons. Br J Obstet Gynaecol 1992;99:296-301.
4.
Hughson M, Farris AB, Douglas-Denton R, et al: Glomerular number and size in autopsy kidneys: the relationship to birth weight. Kidney Int 2003;63:2113-2122.
5.
Charlton JR, Springsteen CH, Carmody JB: Nephron number and its determinants in early life: a primer. Pediatr Nephrol 2014;29:2299-2308.
6.
Zohdi V, Sutherland MR, Lim K, Gubhaju L, Zimanyi MA, Black MJ: Low birth weight due to intrauterine growth restriction and/or preterm birth: effects on nephron number and long-term renal health. Int J Nephrol 2012;2012:136942.
7.
Holland P: Placental insufficiency and its effect on the fetus and adult disease. Lancet 1993;341:827.
8.
Myrie SB, McKnight LL, Van Vkiet BN, Bertolo RF: Low birth weight is associated with reduced nephron number and increased blood pressure in adulthood in a novel spontaneous intrauterine growth-restricted model in Yucatan miniature swine. Neonatology 2011;100:380-386.
9.
Vujic A, Kosutic J, Bogdanovic R, Prijic S, Milicic B, Igrutinovic Z: Sonographic assessment of normal kidney dimensions in the first year of life - a study of 992 healthy infants. Pediatr Nephrol 2007;22:1143-1150.
10.
Lim Y, Kim WS, Kim HS, Choi YH, Cheon JE, Shin SM, Kim IO, Choi JH: Ultrasonographic study of initial size and postnatal growth of kidneys in preterm infants. Neonatology 2014;106:107-113.
11.
Cappuccini B, Torlone E, Ferri C, Arnone S, Troiani S, Bini V, Bellomo G, Barboni G, Di Renzo G: Renal echo-3D and microalbuminuria in children of diabetic mothers: a preliminary study. J Dev Orig Health Dis 2013;4:285-289.
12.
Abrahamson M, Olafsson I, Palsdottir A, Ulvsbaeck M, Lundwall A, Grubb A: Structure and expression of the human cystatin C gene. Biochem J 1990;268:287-294.
13.
Finney H, Newman DJ, Price CP: Adult reference ranges for serum cystatin C, creatinine and predicted creatinine clearance. Ann Clin Biochem 2000;37:49-59.
14.
Uchida K, Gotoh A: Measurement of cystatin-C and creatinine in urine. Clin Chim Acta 2002;323:121-128.
15.
Conti M, Moutereau S, Zater M, Lallali K, Durrbach A, Manivet P, Eschwège P, Loric S: Urinary cystatin C as a specific marker of tubular dysfunction. Clin Chem Lab Med 2006;44:288-291.
16.
Koyner JL, Vaidya VS, Bennett MR, et al: Urinary biomarkers in the clinical prognosis and early detection of acute kidney injury. Clin J Am Soc Nephrol 2010;5:2154-2165.
17.
Herget-Rosenthal S, van Wijk JA, Brocker-Preuss M, et al: Increased urinary cystatin C reflects structural and functional renal tubular impairment independent of glomerular filtration rate. Clin Biochem 2007;40:946-951.
18.
Cohen J: Statistical Power Analysis for the Behavioral Sciences, ed 2. Hillsdale, Lawrence Erlbaum Associates, 1988.
19.
Fogo AB: Glomerular hypertension, abnormal glomerular growth, and progression of renal diseases. Kidney Int 2000;57:S15-S21.
20.
Saint-Faust M, Boubred F, Simeoni U: Renal development and neonatal adaptation. Am J Perinatol 2014;31:773-780.
21.
Puddu M, Podda MF, Mussap M, Tumbarello R, Fanos V: Early detection of microalbuminuria and hypertension in children of very low birth weight. J Matern Fetal Neonatal Med 2009;22:83-88.
22.
Mitchell EKL, Louey S, Cock ML, Harding R, Black MJ: Nephron endowment and filtration surface area in the kidney after growth restriction of fetal sheep. Pediatr Res 2004;55:769-773.
23.
Boubred F, Saint-Faust M, Buffat C, Ligi I, Grandvuillemin I, Simeoni U: Developmental origins of chronic renal disease: an integrative hypothesis. Int J Nephrol 2013;2013:346067.
24.
Kaseda R, Iino N, Hosojima M, Takeda T, Hosaka K, Kobayashi A, Yamamoto K, Suzuki A, Kasai A, Suzuki Y, Gejyo F, Saito A: Megalin-mediated endocytosis of cystatin C in proximal tubule cells. Biochem Biophys Res Commun 2007;357:1130-1134.
25.
Thielemans N, Lauwerys R, Bernard A: Competition between albumin and low-molecular-weight proteins for renal tubular uptake in experimental nephropathies. Nephron 1994;66:453-458.
26.
Nejat M, Hill JV, Pickering JW, Edelstein CL, Devarajan P, Endre ZH: Albuminuria increases cystatin C excretion: implications for urinary biomarkers. Nephrol Dial Transplant 2012;27:iii96-iii103.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.